Arosa Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-700,000
Closed -$5.99M 64
2019
Q3
$5.99M Buy
+700,000
New +$6.86M 1.07% 34
2019
Q2
Sell
-775,000
Closed -$10.9M 65
2019
Q1
$10.9M Buy
+775,000
New +$10.2M 1.96% 19
2018
Q2
Sell
-901,624
Closed -$15.8M 81
2018
Q1
$15.8M Buy
901,624
+213,322
+31% +$4.45M 2.19% 15
2017
Q4
$15.8M Buy
688,302
+565,000
+458% +$11.7M 2.43% 17
2017
Q3
$2.58M Buy
+123,302
New +$2.27M 0.37% 48
2016
Q2
Sell
-980,269
Closed -$17.3M 72
2016
Q1
$17.3M Buy
+980,269
New +$14.6M 1.79% 18
2015
Q2
Sell
-2,121,395
Closed -$39.8M 54
2015
Q1
$39.8M Buy
2,121,395
+1,379,410
+186% +$23.7M 8.7% 1
2014
Q4
$12.3M Buy
+741,985
New +$15.7M 4.1% 8

Other funds holding PTEN

Arosa Capital Management's PTEN Position: Q4 2019 in Review

Arosa Capital Management sold out of Patterson-UTI (PTEN) in Q4 2019, closing a stake of 700,000 shares — an estimated $5.99M sold.

Arosa Capital Management first reported a position in PTEN in Q4 2014 and held it in 8 quarters. The position peaked at $39.8M in Q1 2015. 267 funds tracked by Wall St. Rank hold PTEN as of Q4 2019.

  • Arosa Capital Management reported no remaining Patterson-UTI position as of Q4 2019 after selling out during the quarter.
  • Arosa Capital Management sold 700,000 Patterson-UTI shares in Q4 2019, an estimated $5.99M.
  • Arosa Capital Management first reported a position in Patterson-UTI in Q4 2014 and held it in 8 quarters.
  • Arosa Capital Management's Patterson-UTI position peaked at $39.8M in Q1 2015.
  • 267 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2019.

Based on Arosa Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.